Merus announces appointment of Jason Avery as Chief Business Officer

19-Jun-2012 - Netherlands

Merus B.V., a biopharmaceutical company focused on multispecific human antibody therapeutics, announced that Jason Avery has been appointed as Chief Business Officer.

With a professional background as Head of Business Development at Affitech A/S and Chief Business Officer at Cambridge Antibody Technology, Jason Avery brings extensive industry experience to Merus.

Other news from the department people

More news from our other portals

All FT-IR spectrometer manufacturers at a glance